renal impairment

Related by string. Renal impairment * Rend al . Renal . Renald . Rend Al : chronic renal failure . acute renal failure . End Stage Renal . impaired renal / impairments . Impairment . Impairments . IMPAIRMENT : goodwill impairment charge . mild cognitive impairment . visual impairment . visual impairments * severe renal impairment . moderate renal impairment . mild renal impairment *

Related by context. All words. (Click for frequent words.) 71 renal insufficiency 70 hepatic impairment 69 ACTOplus met 69 severe renal impairment 69 moderate renal impairment 69 renal dysfunction 68 lactic acidosis 68 hypomagnesemia 68 hyperkalemia 68 left ventricular dysfunction 68 hypocalcemia 68 hepatic insufficiency 67 transaminase elevations 67 severe renal insufficiency 67 thrombotic events 67 BENICAR HCT 67 impaired renal 67 β blockers 67 TEAEs 67 orthostatic hypotension 67 hepatotoxicity 67 Erythropoietic therapies may 66 electrolyte abnormalities 66 proliferative diabetic retinopathy 66 mild renal insufficiency 66 APTIVUS r 66 hypercalcemia 66 lipid lowering agents 66 MULTAQ 66 thromboembolic events 66 aminotransferases 66 VIIBRYD 65 elevated ALT 65 benazepril 65 aspartate aminotransferase AST 65 BYSTOLIC 65 antihypertensive medications 65 ATACAND 65 concomitant medications 65 nephrotoxicity 65 oral antidiabetic medication 65 moderate hepatic impairment 65 liver transaminases 65 serum phosphorous 65 PREZISTA r 65 stable angina 65 ALT flares 65 myopathy rhabdomyolysis 65 systolic dysfunction 65 cytopenias 65 hypokalemia 64 extrapyramidal symptoms 64 JANUMET 64 nonvertebral fracture 64 TMP SMX 64 creatinine clearance 64 ACTOplus met XR 64 arterial thromboembolic events 64 heparin induced thrombocytopenia 64 serum phosphate 64 uncontrolled hypertension 64 recurrent ischemia 64 euvolemic 64 nonhematologic adverse reactions 64 Hypotension 64 potentially hepatotoxic 64 ß blockers 64 CrCl 64 serum aminotransferase levels 64 hyperphenylalaninemia HPA due 64 loop diuretics 64 severe hypersensitivity reactions 64 systolic hypertension 64 subclinical hypothyroidism 64 comorbid conditions 64 venlafaxine Effexor 64 transaminases 64 primary generalized tonic 64 hepatic dysfunction 64 transaminase levels 64 hepatorenal syndrome 63 prolonged QT interval 63 beta blocker therapy 63 reflux symptoms 63 antiplatelet medications 63 hypophosphatemia 63 aldosterone antagonists 63 thromboembolic complications 63 HIV HCV coinfected 63 dopaminergic therapy 63 postoperative AF 63 T2DM 63 anemia neutropenia 63 hepatic enzymes 63 thyrotoxicosis 63 loop diuretic 63 lipid elevations 63 liver dysfunction 63 hypercholesterolaemia 63 anticholinergic medications 63 COREG 63 TNF antagonist 63 receiving VELCADE 63 adrenal insufficiency 63 lipid parameters 63 deep venous thromboses 63 carotid stenosis 63 morphometric vertebral fractures 63 metabolic acidosis 63 mcg QD 63 Lactic acidosis 63 AST ALT 63 corticosteroid therapy 63 overactive bladder symptoms 63 primary hypercholesterolemia 63 generalized edema 63 symptomatic hyponatremia 63 renal artery stenosis 63 aortic regurgitation 63 EXJADE 63 NATRECOR R 63 neuropsychiatric symptoms 63 secondary hyperparathyroidism 63 fluid overload 63 atrophic gastritis 63 aldosterone antagonist 62 left ventricular hypertrophy 62 oral antidiabetic drugs 62 intracranial hemorrhage ICH 62 valvular disease 62 urinary retention 62 peginterferon alfa 62 salmeterol HFA MDI 62 elevated serum creatinine 62 HMG CoA reductase inhibitors 62 hypervolemic hyponatremia 62 comorbidities 62 failure NYHA 62 thromboembolic 62 lipid lowering therapies 62 leukopenia 62 DOXIL 62 NYHA Class II 62 virologic failure 62 macroalbuminuria 62 angiotensin converting enzyme inhibitor 62 OADs 62 periprocedural 62 ARIXTRA 62 INFERGEN 62 detrusor overactivity 62 alanine aminotransferase 62 oral antidiabetic agents 62 elevated liver enzymes 62 alpha blocker 62 hypercalciuria 62 severe neutropenia 62 COPD exacerbation 62 Hypersensitivity reactions 62 tolvaptan 62 serum potassium 62 acarbose 62 SHPT 62 pioglitazone HCl 62 Hepatic Impairment 62 QTc prolongation 62 acute phosphate nephropathy 62 venous thrombosis 62 cirrhotic patients 62 QT prolongation 62 dermatologic reactions 62 Hypokalemia 62 MYCAMINE 62 QTc 62 oxycodone CR 62 overt nephropathy 62 FASLODEX 62 levodopa therapy 62 INVEGA ® 62 antihypertensive therapy 62 EDARBI 62 anemia hemoglobin 62 HBeAg negative 62 laboratory abnormalities 62 lupus nephritis 62 severe exacerbations 62 Toxicities 62 bezafibrate 62 non metastatic osteosarcoma 62 IIIa inhibitor 62 del 5q MDS 62 quetiapine Seroquel 62 Vaprisol 62 β blocker 62 thromboembolic disease 62 impaired hepatic 62 hypertriglyceridemia 62 XIENCE V PROMUS Stent 61 vertebral fracture 61 APTIVUS ritonavir 61 ribavirin therapy 61 poor metabolizers 61 metformin accumulation 61 Nesiritide 61 Known hypersensitivity 61 isolated systolic hypertension 61 thiazide 61 pancreatic insufficiency 61 venous thromboembolic events 61 ischemic cardiomyopathy 61 anthracycline therapy 61 recurrent UTI 61 atrioventricular block 61 elevated LDH 61 polyp recurrence 61 androgen deficiency 61 angiotensin converting enzyme inhibitors 61 dapagliflozin plus 61 Prehypertension 61 HeFH 61 LV dysfunction 61 antiarrhythmic drug 61 bacteriuria 61 resynchronization therapy 61 preserved ejection fraction 61 left ventricular systolic 61 renal function 61 follicular lymphoma FL 61 microalbuminuria 61 systemic corticosteroids 61 oral hypoglycemic agents 61 abdominal adiposity 61 metformin monotherapy 61 hematologic toxicity 61 VAPRISOL 61 NNT = 61 autonomic dysfunction 61 Hematologic 61 certolizumab 61 ACEIs 61 acute decompensation 61 unfavorable cytogenetics 61 receiving prophylactic anticoagulation 61 Peripheral edema 61 paroxysmal AF 61 serum creatinine levels 61 acutely decompensated congestive heart 61 Neovascular AMD 61 KETEK 61 symptomatic BPH 61 NYHA Class III 61 infarctions 61 tamsulosin 61 QTc interval 61 administered concomitantly 61 flutamide 61 alanine aminotransferase ALT 61 microvascular disease 61 HBV infections 61 lipohypertrophy 61 elevated triglycerides 61 NOMID 61 EFFEXOR XR 61 TORISEL 61 torsade de pointes 61 purpura ITP 61 tumor lysis syndrome 61 either acutely decompensated 61 unstable angina pectoris 61 myelosuppression 61 mixed hyperlipidemia 61 hyperglycemia 61 haematologic 61 constipation nausea 61 NATRECOR ® 61 hypersensitivity reaction 61 juvenile idiopathic arthritis 61 ACTEMRA TM 61 cinacalcet 61 elevated IOP 61 Thiazolidinediones 61 VaD 61 ACE Inhibitors 61 potassium sparing diuretics 61 relapsed MM 61 diabetic nephropathy 61 elevated LDL cholesterol 61 leucopenia 61 concomitant AEDs 61 ULORIC 61 typical antipsychotics 61 ruboxistaurin 61 vesicoureteral reflux 61 Syndrome RLS 61 rFVIIa 61 aripiprazole Abilify 61 acute GvHD 61 proteinuria 61 candesartan cilexetil 61 NPH insulin 61 antidiabetic drugs 61 mcg kg REBETOL 61 intravascular hemolysis 61 artery stenosis 61 diastolic heart 60 risperidone Risperdal 60 hyperbilirubinemia 60 mRCC 60 acute myocardial infarction AMI 60 pyrexia mucositis sepsis febrile 60 ARCOXIA 60 upper gastrointestinal bleeding 60 alteplase 60 hypoglycemic events 60 adrenal suppression 60 thiazolidinedione 60 receiving XGEVA 60 hyperprolactinemia 60 serum ALT 60 Renal impairment 60 leukemia AML 60 thromboembolism 60 abatacept 60 atherogenic dyslipidemia 60 headache abdominal pain 60 AVANDIA 60 aspirin clopidogrel 60 UA NSTEMI 60 virological failure 60 torsades de pointes 60 contraindication 60 onset diabetes mellitus 60 primary aldosteronism 60 postoperative complication 60 PROCRIT 60 euvolemic hyponatremia 60 reduce serum phosphate 60 Candesartan 60 hepatic failure 60 titrated glipizide 60 AGILECT R 60 inhaled glucocorticoids 60 pyridostigmine 60 decompensated heart failure 60 elevated triglyceride levels 60 efalizumab 60 pulmonary exacerbations 60 GH deficiency 60 alvimopan 60 hepatic function 60 tapentadol ER 60 perioperatively 60 homozygous familial hypercholesterolemia 60 juvenile idiopathic arthritis JIA 60 non squamous NSCLC 60 anaphylactoid reactions 60 atherothrombotic events 60 neutropenia dehydration dyspnea 60 ARCALYST ® 60 dobutamine 60 nonvertebral fractures 60 acitretin 60 paricalcitol 60 thromboprophylaxis 60 PEGINTRON TM 60 HbA1c levels 60 angina pectoris 60 renal toxicity 60 tricyclic antidepressants 60 CHD mortality 60 vWD 60 cTnT 60 intravenous bisphosphonates 60 tipranavir r 60 lopinavir r arm 60 dyslipidaemia 60 conventional antipsychotics 60 multivessel disease 60 serum potassium levels 60 solifenacin 60 thrombocytopenic 60 baseline HbA1c 60 nicardipine 60 endometrial hyperplasia 60 #mg BID [001] 60 onset seizures 60 umol L 60 unresectable HCC 60 co morbidities 60 Chronic Heart Failure 60 bacterial prostatitis 60 SJIA 60 PAOD 60 tardive dyskinesia TD 60 colorectal adenoma 60 ADHF 60 bronchial hyperresponsiveness 60 postoperative atrial fibrillation 60 severe hepatomegaly 60 hypotension 60 NIASPAN 60 Myelosuppression 60 Thrombocytopenia 60 chronic thromboembolic pulmonary 60 refractory gout 60 venous thromboembolic disease 60 serum calcium levels 60 anticholinergics 60 definite stent thrombosis 60 sotalol 60 events TEAEs 60 progressive dyspnea 60 SGPT 60 advanced adenoma 60 pericardial effusion 60 patients undergoing CABG 60 NYHA class 60 invasive candidiasis 60 thrombocytosis 60 hyperlipidemia 60 INCB# [003] 60 antiarrhythmic drugs 60 myocardial ischemia 60 PRADAXA 60 hypercholesterolemia 60 hemorrhagic complications 60 bone marrow suppression 60 hypoglycemic episodes 60 Eltrombopag 60 glycated hemoglobin levels 60 nonischemic 60 INVANZ 60 PASI scores 60 systemic corticosteroid 60 Serious adverse reactions 60 glomerular filtration rate 60 COPAXONE R 60 partial onset seizures 60 postoperative delirium 60 diabetic gastroparesis 60 Barrett esophagus BE 60 hypertension 60 hyperuricemia 60 Infusion Reactions Severe 60 heterozygous FH 60 subclinical hyperthyroidism 60 angina chest 60 antiepileptic drugs AEDs 60 prednisone prednisolone 60 induce orthostatic hypotension 59 CTEPH 59 LUTS 59 IBS C 59 Keppra R 59 recurrent DVT 59 KOMBIGLYZE XR 59 AVELOX 59 serum transaminases 59 achieved ACR# 59 pathologic fractures 59 metabolic alkalosis 59 steatosis 59 psoriatic arthritis PsA 59 Exacerbations 59 diabetic kidney 59 MEVACOR 59 baseline serum creatinine 59 coadministration 59 metastatic malignant 59 BARACLUDE ® 59 discontinuations due 59 HBeAg positive 59 lipid disorders 59 macrovascular events 59 urolithiasis 59 Nocturia 59 nonadherence 59 Fibrates 59 mcg BID 59 carotid IMT 59 hyperglycaemia 59 mild hepatic impairment 59 Vitamin B# deficiency 59 tolterodine ER 59 clonic seizures 59 insulin detemir 59 calculated creatinine clearance 59 pheochromocytoma 59 hypoglycaemic episodes 59 Hypocalcemia 59 haloperidol Haldol 59 voriconazole 59 severe hepatic insufficiency 59 hallucinations dyskinesia 59 Hypercholesterolemia 59 ventricular dysfunction 59 symptomatic hypotension 59 CIMZIA ™ 59 metformin sulfonylurea 59 lipid lowering medications 59 Welchol 59 NSAID therapy 59 posaconazole 59 cerebrovascular accident 59 reflux disease 59 valsartan amlodipine 59 mycophenolate mofetil 59 Primary Hypercholesterolemia 59 microbleeds 59 fragility fracture 59 aminotransferase levels 59 rosuvastatin #mg 59 intravesical therapy 59 rheumatoid arthritis osteoarthritis ankylosing 59 systemic hypotension 59 adverse cytogenetics 59 angiotensin receptor blockers ARBs 59 statin monotherapy 59 QT interval prolongation 59 arterial thrombosis 59 Retreatment 59 steroid dexamethasone 59 candesartan 59 carotid artery stenosis 59 post herpetic neuralgia PHN 59 occlusion CRVO 59 ZYVOX 59 pulmonary infiltrates 59 serum phosphorus 59 LATUDA 59 revascularization procedures 59 Torsades de Pointes 59 chronic renal insufficiency 59 strong CYP#A# inducers 59 estimated glomerular filtration 59 coronary calcification 59 coronary stenosis 59 CVD mortality 59 Oral corticosteroids 59 nonalcoholic steatohepatitis 59 corticosteroid dose 59 intravenous diuretics 59 Dasatinib 59 abnormal lipid 59 elevated intraocular pressure 59 idiopathic Parkinson disease 59 metastatic GIST 59 PREZISTA r arm 59 MAO inhibitors 59 glitazones 59 hematological parameters 59 hyperlipidaemia 59 nephropathy 59 ORENCIA ® 59 EDSS scores 59 NUCYNTA R 59 acute coronary syndromes 59 pulmonary capillary wedge 59 cerebrovascular events 59 abacavir lamivudine 59 Generalized Anxiety Disorder 59 gastrointestinal GI motility disorders 59 ZOMETA 59 smoldering multiple myeloma 59 Telithromycin 59 chronic immune thrombocytopenic 59 hyperreflexia 59 hip BMD 59 Thrombolysis 59 lipid abnormalities 59 irbesartan 59 Subarachnoid hemorrhage 59 tirofiban 59 severe mitral regurgitation 59 progressive PsA 59 bronchospasm 59 syncope 59 neutropenia thrombocytopenia 59 RoACTEMRA 59 AA Amyloidosis 59 weekly subcutaneous injections 59 angiotensin II receptor blockers 59 lymphopenia 59 chronic bronchitis AECB 59 alemtuzumab treated 59 Eisenmenger syndrome 59 Renal dysfunction 59 ziprasidone Geodon 59 DULERA 59 HbA 1c levels 59 stage IIIB 59 dysglycemia 59 oral levofloxacin 59 cardiac conduction 59 serum sodium 59 chronic hepatitis cirrhosis 59 parathyroid carcinoma 59 antihypertensive agents 59 chronic renal disease 59 cutaneous manifestations 59 lumbar spine bone 59 thiazide diuretic 59 gastrointestinal ulcers 59 hyperphosphatemia 59 unknown etiology 59 serum lipid levels 59 deletion 5q 59 divalproex sodium 59 angiotensin receptor blockers 59 transferrin saturation 59 OSAHS 59 hypertensives 59 autoantibody positive 59 decompensated liver disease 59 GnRH agonists 59 Cognitive Impairment 59 extrapyramidal symptoms EPS 59 rhythm disturbances 59 antidiabetic medication 59 salmeterol fluticasone 59 plasma creatinine 59 Non inferiority 59 Non Alcoholic Steatohepatitis 59 antihypertensives 59 pericardial effusions 59 generalized anxiety disorder GAD 59 Peginterferon Alfa 2a 59 eosinophilic asthma 59 elevated creatinine 59 citalopram Celexa 59 Adenomas 59 unstable angina UA 59 OAB symptoms 59 severe aortic stenosis 59 K ras mutations 59 Non Alcoholic Fatty 59 antidiabetic medications 58 candidemia 58 latent tuberculosis infection 58 methimazole 58 narrow angle glaucoma 58 chronic periodontitis 58 mg BID 58 antihypertensive drugs 58 CANCIDAS 58 hepatic enzyme 58 post thrombotic syndrome 58 hyperparathyroidism 58 carotid intima media 58 RLAI 58 severe gastroparesis 58 acute coronary syndromes ACS 58 Atacand 58 glomerular filtration 58 hsCRP levels 58 dalteparin 58 severe hypoglycemia 58 electrolyte disturbances 58 discontinued Viread 58 aortic valve stenosis 58 proliferative retinopathy 58 intermittent claudication 58 invasive fungal infections 58 occlusive disease 58 blood Phe levels 58 liver histology 58 immunosuppressive agents 58 hypovolemia 58 paroxetine Paxil 58 neurologic complications 58 intracranial bleeding 58 thrombophlebitis 58 biliary tract disease 58 eosinophilic pneumonia 58 NYHA 58 FROVA 58 fluvastatin 58 dual endothelin receptor antagonist 58 rosuvastatin Crestor 58 Postoperative complications 58 thioridazine 58 SPRYCEL ® 58 neurologic symptoms 58 bosentan 58 echocardiographic parameters 58 receiving golimumab 58 failure ADHF 58 active ankylosing spondylitis 58 phosphate binders 58 DMARD therapy 58 SCr 58 cholecystitis 58 LYSTEDA 58 metastatic RCC 58 acute gout flares 58 symptomatic paroxysmal AF 58 hemodialysis patients 58 Proteinuria 58 CTAP# Capsules 58 hypertension diabetes mellitus 58 Mg Uk 58 coronary revascularization procedures 58 aminotransferase ALT 58 reoperations 58 glulisine 58 nausea vomiting headache 58 colorectal liver metastases 58 pancytopenia 58 receiving immunosuppressive therapy 58 Hypertensive 58 antithrombotic therapy 58 ZOLINZA 58 cabergoline 58 hypoxemia 58 Stent thrombosis 58 cardiomyopathies 58 NOXAFIL 58 postoperative ileus POI 58 subtrochanteric 58 infective endocarditis 58 Overactive Bladder 58 myelodysplastic myeloproliferative diseases 58 CHD CVD 58 Pioglitazone 58 REMICADE ® 58 microvascular complications 58 undergoing CABG 58 Lantus ® 58 LVEF 58 LVSD 58 oral FTY# 58 perioperative mortality 58 pulmonary hypertension PH 58 analgesic medications 58 chronic metabolic acidosis 58 generalized tonic clonic seizures 58 salmeterol inhalation powder 58 symptomatic VTE 58 hypokalemia hypomagnesemia 58 mCRC acneform rash 58 sargramostim 58 fosamprenavir 58 LV hypertrophy 58 optic neuropathy 58 metastatic renal cell carcinoma 58 dyslipidemia 58 myocardial infarction stroke 58 lamotrigine 58 thrombolytic agents 58 anemia thrombocytopenia 58 bridging fibrosis 58 acromegalic patients 58 ALT elevations 58 bladder dysfunction 58 amenorrhoea 58 recurrent VTE 58 myeloproliferative diseases 58 endothelin receptor antagonists 58 pulmonary toxicity 58 WARNINGS Myopathy Rhabdomyolysis 58 macular edema 58 T1DM 58 cardiac toxicity 58 hyperammonemia 58 Glimepiride 58 Starlix 58 unresectable 58 ischemic complications 58 primary axillary hyperhidrosis 58 ejection fractions 58 neurogenic orthostatic hypotension 58 alpha interferons 58 4mg/kg 58 blood phenylalanine Phe 58 hematologic adverse 58 infarction NSTEMI 58 canakinumab 58 elevated lipase 58 anticonvulsant medications 58 inhaled corticosteroids ICS 58 psychiatric comorbidities 58 pulmonary exacerbation 58 urinary oxalate 58 kidney dysfunction 58 amisulpride 58 lipid lowering drugs 58 angiotensin converting enzyme ACE 58 atypical antipsychotic medications 58 esophagitis 58 juvenile myoclonic epilepsy 58 xanthine oxidase inhibitor 58 VTE prophylaxis 58 bisoprolol 58 vasomotor symptoms 58 refractory NSCLC 58 serum urate levels 58 nonalcoholic steatohepatitis NASH 58 binary restenosis 58 thrombotic complications 58 ocular adverse 58 mitral regurgitation MR 58 hypertensive patients 58 hyperoxaluria 58 calcineurin inhibitors 58 atazanavir 58 advanced adenomas 58 #.#mg/dL 58 ACTOS 58 serum calcium 58 spirometric 58 LOVENOX R 58 lichen planus 58 rizatriptan 58 intracranial hypertension 58 antiplatelet drugs 58 thyrotropin levels 58 serum sodium levels 58 peripheral arterial occlusive disease 58 VTEs 58 metformin sulphonylurea 58 antiarrhythmic medications 58 colesevelam HCl 58 myocardial infarctions 58 CIMZIA TM certolizumab pegol 58 Chronic Constipation 58 DMARDS 58 lipid levels 58 ventricular tachyarrhythmia 58 Duloxetine 58 Amiodarone 58 coronary revascularization 58 Coronary Artery Bypass Graft 58 REVLIMID ® 58 ® pioglitazone HCl 58 perimenopausal women 58 serum uric acid 58 stenoses 58 chronic eosinophilic leukemia 58 ARICEPT 58 aspartate aminotransferase 58 dosing frequency 58 afterload 58 silent ischemia 58 zonisamide SR 58 breast abscesses 58 phenytoin 58 tapentadol IR 58 left ventricular diastolic 58 Elitek 58 ketoacidosis hyperosmolar coma 58 Hyperkalemia 58 TZDs 58 DMARD 58 neutropaenia 58 plasma uric acid 58 ALVESCO 58 pentoxifylline 58 serotonergic drugs 58 variceal bleeding 58 prolactin levels 58 hypertension congestive heart 58 enalapril 58 known sulfonamide allergy 58 flecainide 58 suboptimal adherence 58 receiving INTRON 58 Adalimumab 58 ADPKD 58 SAPHRIS 58 angina myocardial infarction 58 Hurthle cell 58 ZIAGEN 58 fasting insulin 58 CK MB 58 albumin excretion 57 virologic response 57 prescribed statins 57 zolmitriptan 57 recurrent wheezing 57 serum phosphate levels 57 GnRH agonist 57 macrovascular disease 57 hypovitaminosis D 57 SUSTENNA TM 57 fibrate 57 asymptomatic PAD 57 varices 57 mIU L 57 Anticoagulants 57 cardiac tamponade 57 thrombocytopenia 57 pimozide 57 Heavy menstrual bleeding 57 atherothrombosis 57 decompensation 57 mL/min/#.# m 2 57 Complication rates 57 DETROL LA 57 coronary insufficiency 57 events AEs 57 HMG CoA reductase inhibitor 57 eplerenone 57 NYHA functional class 57 RLS symptoms 57 renal disease 57 hydroxymethyl coenzyme 57 Angioedema 57 vandetanib 57 MAOIs 57 ischemic colitis 57 acne vulgaris 57 kidney insufficiency 57 hepatic toxicity 57 alpha blockers 57 AIOD 57 BANZEL 57 x ULN 57 PRISTIQ 57 gemfibrozil 57 INVEGA R 57 elevated transaminases 57 postoperative morbidity 57 mitral insufficiency 57 NMDA antagonists 57 CONCERTA 57 GERD symptoms 57 neurological abnormalities 57 leukotriene receptor antagonists 57 hepatic encephalopathy 57 Clinically significant 57 FluCAM arm 57 coronary artery disease 57 neuroleptics 57 BENICAR 57 ULTRAM ER 57 ertapenem 57 gadobutrol 57 diarrhea nausea vomiting 57 headache nasopharyngitis 57 milrinone 57 revascularizations 57 terlipressin 57 antidiabetic drug 57 metformin HCl 57 thienopyridine 57 syncope fainting 57 CYP #A# 57 nephrotoxic drugs 57 Mitral regurgitation 57 acute hepatic 57 gestational diabetes mellitus 57 aplastic anemia AA 57 Index CDAI 57 hyperhomocysteinemia 57 primidone 57 lumiracoxib 57 non selective NSAIDs 57 generalized seizures 57 hypercalcaemia 57 unmeasured confounders 57 anticholinergic medication 57 recurrent atrial fibrillation 57 beta blockers ACE inhibitors 57 primary hyperparathyroidism 57 primary immunodeficiency PI 57 maximal doses 57 ipsilateral stroke 57 nondiabetic patients 57 atherosclerotic disease 57 Renal Impairment 57 cirrhotic 57 tricyclics 57 glucocorticoid therapy 57 asthma exacerbation 57 biologic DMARD 57 methotrexate monotherapy 57 thiazides 57 oxycodone IR 57 osteoporotic vertebral compression fractures 57 HSCT 57 reflux disease GERD 57 Ischemic 57 Hepatotoxicity 57 PsA 57 urinary symptoms 57 serum IGF 57 diabetic neuropathic pain 57 SCIg 57 diabetes mellitus 57 mild renal impairment 57 every ERBITUX infusion 57 venlafaxine XR 57 antiplatelet agents 57 Angiotensin receptor blockers 57 incidence ≥ 57 elevated depressive symptoms 57 clomipramine 57 HPA axis suppression 57 symptomatic intracerebral hemorrhage

Back to home page